Richard Green's work sequencing ancient DNA has fundamentally changed how scientists understand human evolution and has enabled forensic breakthroughs that solved cold cases across the country. The UC Santa Cruz researcher was among seven innovators recognized with the Distinguished Lifetime Achievement Award at the inaugural 2026 UC Regents Innovation Awards, held on Wednesday, September 16, 2026.

What Makes DNA Sequencing Innovation So Transformative?

Green's contributions to genomics extend far beyond academic interest. His innovations in DNA sequencing technology have enabled researchers to recover and analyze genetic material from ancient human remains, leading to breakthrough discoveries about human evolution. Most notably, his work contributed to the draft sequence of the Neanderthal genome, a milestone that reshaped our understanding of how modern humans and our extinct cousins diverged and interbred.

Beyond evolutionary science, Green's sequencing advances have practical applications in criminal justice. His company, Astrea Forensics, applies these DNA sequencing methods to help law enforcement solve cold cases across the country, demonstrating how fundamental research can directly improve public safety.

How Has Green Built an Ecosystem of Genomics Innovation?

Green's impact extends beyond his own research. He founded two additional startups in the genomics space: Dovetail Genomics and Claret Biosciences, both launched at the UC Santa Cruz branch of the California Institute of Quantitative Biosciences (QB3), where he now serves as director. This entrepreneurial track record shows how academic breakthroughs can spawn multiple commercial ventures that advance the field.

Green's recognition comes alongside other UC researchers whose work is reshaping biology and medicine. The 2026 UC Regents Innovation Awards honored 23 exceptional innovators across five categories, chosen from nominees representing all 10 UC campuses and three affiliated national laboratories.

What Other Genomics and Biology Breakthroughs Were Recognized?

Several other award winners are advancing AI-driven and precision medicine approaches that complement Green's foundational sequencing work:

• Gene Editing for Rare Diseases: Fyodor Urnov at UC Berkeley leads development of on-demand gene-editing treatments for children born with rare genetic disorders using CRISPR technology. His team established a framework that cuts the development cost of personalized CRISPR cures by 90%, making treatments more accessible to families worldwide.
• Protein Evolution Acceleration: Chang Liu at UC Irvine invented OrthoRep, an artificial DNA replication system that accelerates targeted protein evolution. His system compresses biological evolutionary timelines from years to days, allowing researchers to rapidly engineer new therapeutic proteins and cancer-fighting antibodies.
• Microbiome-Based Immunotherapy: Susan Lynch at UC San Francisco established a new paradigm for preventing food allergies, asthma, and other immune-related conditions. In clinical trials of a living microbial therapy that boosts healthy gut microbes in infants, atopic dermatitis decreased by 64% and food allergies by 77% in high-risk infants.
• Infectious Disease Diagnostics: Joseph DeRisi at UC San Francisco founded Delve Bio to pioneer a metagenomic test that diagnoses complex central nervous system infections when conventional testing fails. His flagship service, Delve Detect, reduces unnecessary procedures and shortens hospital stays.

These innovations reflect a broader shift in biology research toward combining computational approaches, AI-assisted analysis, and precision medicine. Green's foundational work in DNA sequencing technology has helped enable many of these downstream applications, from diagnosing rare infections to engineering new therapeutic proteins.

The UC Regents Innovation Awards program itself represents an institutional commitment to recognizing researchers and entrepreneurs whose work moves from the laboratory into real-world impact. By honoring innovators across academic research, startup creation, and lifetime achievement, the University of California is signaling that the future of biology and genomics depends on scientists who can bridge fundamental discovery and practical application.